Levetiracetam News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Levetiracetam. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Levetiracetam Today - Breaking & Trending Today

Johnson & Johnson-Partnered Addex Therapeutics' Epilepsy Candidate Fails Mid-Stage Study, Stock Tanks

Monday, Addex Therapeutics (NASDAQ:ADXN) released top-line data from a Phase 2 epilepsy study evaluating adjunctive ADX71149 (JNJ-40411813) administration in patients with focal onset seizures with suboptimal response to levetiracetam or brivaracetam. The company is collaborating with Johnson & Johnson’s (NYSE:JNJ) Janssen Pharmaceuticals Inc. The Phase 2 study did not achieve statistical significance for the primary endpoint of time for patients to reach baseline seizure count when ADX71149 was ....

Roger Mills , Tim Dyer , Janssen Pharmaceuticals Inc , Addex Therapeutics , Janssen Pharmaceuticals , Chief Medical Officer , Stock Market Game , Benzinga Pro , Day Trial , Stock Tanks , Roger Mills , Statistical Significance , Janssen Pharmaceuticals Inc , Chief Medical Officer ,

Some antiseizure drugs can cause extensive rash, FDA warns

FDA warns of rare, life-threatening reaction to antiseizure medications levetiracetam and clobazam, including Keppra and Elepsia XR. ....

Eppra Xr , Lepsia Xr ,

Shortages of Antiseizure Meds Continue, More Common Among Generics: Australian Report

Between 2019 and 2020, there were 97 reported shortages among sponsor-reported antiseizure medications in Australia, 93% of which were generic brands. ....

United States , Medicine Shortages Reports Database , Antiseizure Medications ,